Beacon Therapeutics

Performance

About Beacon Therapeutics

Beacon Therapeutics is a clinical-stage biotechnology company focused on restoring and preserving vision through ophthalmic gene therapy. The company concentrates on blinding retinal diseases such as X-linked retinitis pigmentosa, dry age-related macular degeneration, and cone-rod dystrophy, employing AAV-based gene therapies. Headquartered with emphasis on ocular indications, Beacon aims to translate scientific innovation into meaningful patient outcomes through ongoing clinical trials and partnerships. The organization positions itself at the forefront of gene therapy for eye diseases, driven by a mission to save and restore sight for individuals affected by inherited retinal disorders.